11 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #AACE #2018 # ... Control #Medication #Algorithm ... Endocrinology #PrimaryCare
Acne treatment algorithm suggested by Gollnick et al - Mild Moderate and Severe Acne
#Management #Dermatology #PrimaryCare
Acne treatment algorithm ... Moderate and Severe Acne ... #Dermatology #PrimaryCare ... #Acne #Treatment ... #Algorithm
AAFP Severity-based approach to treating acne.

#Management #Dermatology #PrimaryCare #Acne #Algorithm #Treatment
approach to treating acne ... #Dermatology #PrimaryCare ... #Acne #Algorithm ... #Treatment
Clinical treatment algorithm for acne. BPO = benzoyl peroxide, clinda = clindamycin, dashed line = optional
Clinical treatment ... algorithm for acne ... #Management #PrimaryCare ... #Acne #Treatment ... #Algorithm
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment ... Algorithm Evaluate ... Postmenopausal #Treatment ... #Algorithm #Management
Global Alliance algorithm to improve outcomes in acne.
†With small nodules (>0.5–1 cm).
‡Consider physical removal of comedones.
§Second
Global Alliance algorithm ... improve outcomes in acne ... #Dermatology #PrimaryCare ... #Acne #Treatment ... #Algorithm
Outpatient Hypertension Management Algorithm
Monotherapy: 
 • Thiazide/thiazide-like 
 • ACE-I (non-black patients), 
 • ARB
Hypertension Management Algorithm ... thiazide-like • ACE-I ... Combined: • ACE-I ... ARB + CCB • ACE-I ... #PrimaryCare
Emergent Hyperkalemia Treatment Algorithm
ECG changes, weakness, K+ >6.5 Or renal insufficiency with K >5.5 with cellular
Emergent Hyperkalemia Treatment ... Algorithm ECG ... as a standalone treatment ... offending agent (ACE-I ... #Algorithm #Management
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... conditions, RAAS meds ... ACE inhibitors,
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
• Avoid ARB/ACE-I ... teratogenic GDMT meds ... (e.g., ACE/ARB) ... management #cardiology #treatment